Anzalone Christopher Richard (CIK 0001423029)

Latest company ownership

Shares held
3,921,255
Last filed at
Apr 11, 2025
Confidence Score
16.0
2025Q4
Confidence Score History
2010Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 17, 2025 Dec 19, 2025 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 16.3 -85,000 -2.17% $5.4M
Dec 12, 2025 Dec 16, 2025 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 40.0 -4,298 -0.11% $12.3M
Apr 9, 2025 Apr 11, 2025 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 17.5 -141,122 -3.47% $1.5M
Mar 13, 2025 Mar 17, 2025 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 92.5 +288,575 7.65% $775K
Mar 3, 2025 Mar 5, 2025 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 26.3 -300,000 -7.36% $5.3M
Jan 2, 2025 Jan 6, 2025 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 48.8 -11,520 -0.31% $219.5K
Dec 23, 2024 Dec 23, 2024 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 48.8 -12,563 -0.33% $246.1K
Dec 18, 2024 Dec 20, 2024 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 85.0 +73,288 1.97% $567.5K
Jan 31, 2024 Feb 2, 2024 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 40.0 -57,499 -1.52% $1.9M
Jan 2, 2024 Jan 4, 2024 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 46.3 -9,952 -0.27% $308.6K
Dec 20, 2023 Dec 22, 2023 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 46.3 -12,000 -0.32% $342.5K
Oct 25, 2023 Oct 27, 2023 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 45.0 -24,338 -0.65% $589.2K
Sep 18, 2023 Sep 20, 2023 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 40.0 -57,755 -1.51% $1.6M
May 3, 2023 May 5, 2023 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 27.5 -104,928 -0.92% $4.1M
Feb 11, 2022 Feb 14, 2022 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 31.3 -146,388 -3.48% $7.6M
Dec 15, 2021 Dec 17, 2021 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 40.0 -60,000 -1.83% $4.1M
Oct 20, 2021 Oct 22, 2021 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 40.0 -65,000 -1.94% $4.3M
Dec 8, 2020 Dec 10, 2020 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 35.0 -55,000 -0.44% $3.8M
Oct 23, 2020 Oct 23, 2020 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 31.3 -100,000 -3.84% $5.8M
Aug 13, 2020 Aug 14, 2020 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 40.0 -50,000 -1.88% $2.1M
Jun 25, 2020 Jun 26, 2020 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 32.5 -100,000 -3.70% $3.9M
Dec 24, 2019 Dec 27, 2019 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 31.3 -83,333 -4.41% $5.3M
Dec 12, 2019 Dec 13, 2019 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 21.3 -183,333 -8.85% $12.3M
Dec 2, 2019 Dec 4, 2019 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 36.3 -50,000 -2.36% $3.4M
Oct 10, 2019 Oct 11, 2019 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 17.5 -56,325 -2.59% $1.8M
Sep 25, 2019 Sep 27, 2019 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 30.0 -20,000 -0.93% $565K
Sep 20, 2019 Sep 24, 2019 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 17.5 -112,650 -1.30% $3.2M
Apr 3, 2019 Apr 5, 2019 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 20.0 -50,000 -2.33% $965K
Dec 19, 2018 Dec 21, 2018 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 27.5 -90,000 -5.51% $1.3M
Dec 12, 2018 Dec 14, 2018 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 27.5 -90,000 -5.23% $1.3M
Nov 9, 2018 Nov 9, 2018 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 32.5 -81,500 -4.52% $1.2M
Aug 31, 2018 Sep 5, 2018 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 23.8 -164,834 -8.37% $2.4M
Mar 16, 2018 Mar 16, 2018 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 45.0 -26,000 -1.30% $192.4K
Mar 13, 2018 Mar 15, 2018 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 20.0 -300,000 -13.07% $2.2M
Dec 13, 2016 Dec 15, 2016 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 40.0 -300,444 -26.89% $381.6K
Dec 30, 2015 Jan 4, 2016 ARROWHEAD PHARMACEUTICALS, INC. CEO Sell 97.5 +481,288 77.61% $359.9K
Oct 15, 2014 Oct 15, 2014 ARROWHEAD PHARMACEUTICALS, INC. CEO Buy 90.0 +16,000 6.55% $101.1K
Oct 15, 2014 Oct 15, 2014 ARROWHEAD PHARMACEUTICALS, INC. CEO Buy 90.0 +16,000 6.55% $101.1K
Aug 31, 2010 Aug 31, 2010 ARROWHEAD PHARMACEUTICALS, INC. CEO Buy 82.5 +10,000 3.01% $8.9K
Aug 27, 2010 Aug 30, 2010 ARROWHEAD PHARMACEUTICALS, INC. CEO Buy 82.5 +10,000 3.11% $8.9K